Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Raya, Bahaa, Madhi, Shabir A., Omer, Saad B., Amirthalingam, Gayatri, Giles, Michelle L., Flanagan, Katie L., Zimmermann, Petra, O’Ryan, Miguel, Safadi, Marco A., Papaevangelou, Vassiliki, Maertens, Kirsten, Wanlapakorn, Nasamon, Diaz-Brito, Vicens, Tommelein, Eline, Esposito, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733958/
https://www.ncbi.nlm.nih.gov/pubmed/35003137
http://dx.doi.org/10.3389/fimmu.2021.808064
Descripción
Sumario:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.

Ejemplares similares